MAPT and Alzheimer disease: An investigation into the evolution of brain lesions and network alterations in AD—fueled by the presence of amyloid and tau biomarkers—upregulates theta power in the mid-frontal cortex, posterior cingulate cortex (PCC), and precuneus (Pc).